BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15616662)

  • 1. Therapeutic manipulations of peroxynitrite.
    Salvemini D; Jensen MP; Riley DP; Misko TP
    Drug News Perspect; 1998 May; 11(4):204-14. PubMed ID: 15616662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide and cellular stress response in brain aging and neurodegenerative disorders: the role of vitagenes.
    Calabrese V; Boyd-Kimball D; Scapagnini G; Butterfield DA
    In Vivo; 2004; 18(3):245-67. PubMed ID: 15341181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excitotoxic brain damage involves early peroxynitrite formation in a model of Huntington's disease in rats: protective role of iron porphyrinate 5,10,15,20-tetrakis (4-sulfonatophenyl)porphyrinate iron (III).
    Pérez-De La Cruz V; González-Cortés C; Galván-Arzate S; Medina-Campos ON; Pérez-Severiano F; Ali SF; Pedraza-Chaverrí J; Santamaría A
    Neuroscience; 2005; 135(2):463-74. PubMed ID: 16111817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
    Sas K; Robotka H; Toldi J; Vécsei L
    J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting peroxynitrite driven nitroxidative stress with synzymes: A novel therapeutic approach in chronic pain management.
    Salvemini D; Neumann W
    Life Sci; 2010 Apr; 86(15-16):604-14. PubMed ID: 19576230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological strategies for the regulation of inducible nitric oxide synthase: neurodegenerative versus neuroprotective mechanisms.
    Pannu R; Singh I
    Neurochem Int; 2006 Jul; 49(2):170-82. PubMed ID: 16765486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress and neurotoxicity.
    Sayre LM; Perry G; Smith MA
    Chem Res Toxicol; 2008 Jan; 21(1):172-88. PubMed ID: 18052107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlorinative stress: an under appreciated mediator of neurodegeneration?
    Yap YW; Whiteman M; Cheung NS
    Cell Signal; 2007 Feb; 19(2):219-28. PubMed ID: 16959471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The chemical biology of clinically tolerated NMDA receptor antagonists.
    Chen HS; Lipton SA
    J Neurochem; 2006 Jun; 97(6):1611-26. PubMed ID: 16805772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview.
    Mariani E; Polidori MC; Cherubini A; Mecocci P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Nov; 827(1):65-75. PubMed ID: 16183338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondria as targets for chemotherapy.
    Gogvadze V; Orrenius S; Zhivotovsky B
    Apoptosis; 2009 Apr; 14(4):624-40. PubMed ID: 19205885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular effects of peroxynitrite.
    Uppu RM; Nossaman BD; Greco AJ; Fokin A; Murthy SN; Fonseca VA; Kadowitz PJ
    Clin Exp Pharmacol Physiol; 2007 Sep; 34(9):933-7. PubMed ID: 17645643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPAR: a therapeutic target in Parkinson's disease.
    Chaturvedi RK; Beal MF
    J Neurochem; 2008 Jul; 106(2):506-18. PubMed ID: 18384649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The physiology and pathophysiology of nitric oxide in the brain.
    Guix FX; Uribesalgo I; Coma M; Muñoz FJ
    Prog Neurobiol; 2005 Jun; 76(2):126-52. PubMed ID: 16115721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metalloporphyrins as a therapeutic drug class against peroxynitrite in cardiovascular diseases involving ischemic reperfusion injury.
    Rabkin SW; Klassen SS
    Eur J Pharmacol; 2008 May; 586(1-3):1-8. PubMed ID: 18395709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genes and the environment in neurodegeneration.
    Coppedè F; Mancuso M; Siciliano G; Migliore L; Murri L
    Biosci Rep; 2006 Oct; 26(5):341-67. PubMed ID: 17029001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxynitrite: biochemistry, pathophysiology and development of therapeutics.
    Szabó C; Ischiropoulos H; Radi R
    Nat Rev Drug Discov; 2007 Aug; 6(8):662-80. PubMed ID: 17667957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intracellular signaling pathways, apoptosis and neurodegenerative diseases].
    Marcilhac A
    Psychol Neuropsychiatr Vieil; 2004 Sep; 2(3):203-14. PubMed ID: 15689335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of Disease: astrocytes in neurodegenerative disease.
    Maragakis NJ; Rothstein JD
    Nat Clin Pract Neurol; 2006 Dec; 2(12):679-89. PubMed ID: 17117171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.